Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
m |
|||
(91 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | :Co-chairs: | + | :Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE |
− | + | ||
− | + | * [http://tinyurl.com/QIBA-CEUS-Roster Roster] | |
+ | |||
==Project Snapshot== | ==Project Snapshot== | ||
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging. | The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging. | ||
− | + | '''Project Descriptions:''' | |
− | * | + | *[[Media:Project Description CEUS QIBA final_MA.docx | Project Description / Outline of the group's planned work]] |
+ | *[[Media:QIBA CEUS project-summary table.pdf | Summary Table of Project]] | ||
+ | |||
+ | |||
+ | '''CEUS Biomarker Committee Proposal:''' | ||
+ | *[[Media:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA CEUS Biomarker Committee Proposal]] | ||
+ | |||
+ | |||
+ | ==Recent Meetings== | ||
+ | '''Approved Call Summaries:''' | ||
+ | |||
+ | *[[Media:2023_07-14 QIBA CEUS BC Call Summary-FINAL.pdf|July 14, 2023]] | ||
+ | *[[Media:05 12 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|May 12, 2023]] | ||
+ | *[[Media:04 14 2023 QIBA CEUS BC Call Summary-FINAL.pdf|April 14, 2023]] | ||
+ | *[[Media:03 10 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 10, 2023]] | ||
+ | *[[Media:02 10 2023 QIBA CEUS BC Call Summary-FINAL.pdf|February 10, 2023]] | ||
+ | *[[Media:01 13 2023 QIBA CEUS BC Call Summary-FINAL.pdf|January 13, 2023]] | ||
− | + | *[[Media:12 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|December 9, 2022]] | |
− | *[[CEUS BC Call Summaries]] | + | *No calls in October or November |
+ | *[[Media:09 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|September 9, 2022]] | ||
+ | *[[Media:08 12 2022 QIBA CEUS BC Call Summary-FINAL-2.pdf|August 12, 2022]] | ||
+ | *[[Media:07 15 2022 QIBA CEUS BC Call Summary-FINAL.pdf|July 15, 2022]] | ||
+ | *[[Media:06 10 2022 QIBA CEUS BC Call Summary-FINAL.pdf|June 10, 2022]] | ||
+ | *[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]] | ||
+ | *[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]] | ||
+ | *[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]] | ||
+ | *[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]] | ||
+ | |||
+ | |||
+ | '''''[[US CEUS Call Summary Archive]]''''' | ||
+ | |||
+ | [[CEUS Task Force (TF) Call Summaries]] | ||
− | |||
==Working Documents== | ==Working Documents== | ||
+ | *[[Media:QIBA CEUS Task Forces - Next Steps.docx| QIBA CEUS Task Forces - Next Steps]] | ||
− | |||
− | |||
==Statistical Reference Documents== | ==Statistical Reference Documents== | ||
− | |||
==Workflow Documents== | ==Workflow Documents== | ||
Line 31: | Line 58: | ||
==Reference Materials== | ==Reference Materials== | ||
− | |||
− | |||
− | + | Original Proposal to the QIBA Steering Committee: | |
− | [[ | + | *[[Media: QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA Committee for Quantitative Contrast Enhanced Ultrasound Proposal]] |
+ | |||
+ | Vendor Press Release: | ||
+ | *[[Media:US-20160404-PR_221236_LUMASON_Liver-PR_0.pdf|FDA Approval for LUMASON® Press Release]] | ||
+ | Presentations: | ||
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]] | *[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]] | ||
− | *[[Media: | + | *[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin Presentation]] |
Latest revision as of 18:48, 21 December 2023
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- December 9, 2022
- No calls in October or November
- September 9, 2022
- August 12, 2022
- July 15, 2022
- June 10, 2022
- May 13, 2022
- March 11, 2022
- February 11, 2022
- January 14, 2022
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: